DevelRx is delighted to announce that the University of Bath and DevelRx have agreed to co-sponsor a PhD project entitled “Mu and kappa opioid receptors in addictive behaviour”.

DevelRx is delighted to announce that the University of Bath and DevelRx have agreed to co-sponsor a PhD project entitled “Mu and kappa opioid receptors in addictive behaviour”.

The 3.5 year project will be based in the Department of Pharmacy and Pharmacology commencing in September 2020.

Co-supervisors on the project are Dr Chris Bailey (Department of Pharmacy and Pharmacology), Prof Sue Wonnacott (Department of Biochemistry) and DrSarah Bailey (Department of Pharmacy and Pharmacology). David Heal is a Visiting Professor in the Department of Pharmacy and Pharmacology at the University of Bath.